1. Home
  2. LSTA vs GROW Comparison

LSTA vs GROW Comparison

Compare LSTA & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • GROW
  • Stock Information
  • Founded
  • LSTA 1980
  • GROW 1968
  • Country
  • LSTA United States
  • GROW United States
  • Employees
  • LSTA N/A
  • GROW N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • GROW Investment Managers
  • Sector
  • LSTA Health Care
  • GROW Finance
  • Exchange
  • LSTA Nasdaq
  • GROW Nasdaq
  • Market Cap
  • LSTA 31.2M
  • GROW 32.9M
  • IPO Year
  • LSTA N/A
  • GROW N/A
  • Fundamental
  • Price
  • LSTA $2.51
  • GROW $2.44
  • Analyst Decision
  • LSTA Strong Buy
  • GROW
  • Analyst Count
  • LSTA 1
  • GROW 0
  • Target Price
  • LSTA $15.00
  • GROW N/A
  • AVG Volume (30 Days)
  • LSTA 58.9K
  • GROW 27.6K
  • Earning Date
  • LSTA 02-27-2025
  • GROW 02-12-2025
  • Dividend Yield
  • LSTA N/A
  • GROW 3.69%
  • EPS Growth
  • LSTA N/A
  • GROW N/A
  • EPS
  • LSTA N/A
  • GROW 0.04
  • Revenue
  • LSTA N/A
  • GROW $9,421,000.00
  • Revenue This Year
  • LSTA N/A
  • GROW N/A
  • Revenue Next Year
  • LSTA N/A
  • GROW N/A
  • P/E Ratio
  • LSTA N/A
  • GROW $66.14
  • Revenue Growth
  • LSTA N/A
  • GROW N/A
  • 52 Week Low
  • LSTA $2.19
  • GROW $2.38
  • 52 Week High
  • LSTA $4.20
  • GROW $2.95
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 40.33
  • GROW 48.78
  • Support Level
  • LSTA $2.51
  • GROW $2.43
  • Resistance Level
  • LSTA $2.66
  • GROW $2.49
  • Average True Range (ATR)
  • LSTA 0.19
  • GROW 0.04
  • MACD
  • LSTA -0.01
  • GROW -0.00
  • Stochastic Oscillator
  • LSTA 17.50
  • GROW 25.00

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

Share on Social Networks: